Angelalign Technology (SEHK:6699): Assessing Valuation After Recent Share Price Uptick

Simply Wall St.

Oct 04

Angelalign Technology (SEHK:6699) has experienced a modest uptick in its stock price over the past week, even as broader sentiment in the healthcare sector remains mixed. Investors are closely ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2572639630"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572639630\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572639630?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2025-10-04 03:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572639630","market":"sg","top_or_hot":-1,"title":"Angelalign Technology (SEHK:6699): Assessing Valuation After Recent Share Price Uptick","media":"Simply Wall St.","content":"<div>\n<p>Angelalign Technology (SEHK:6699) has experienced a modest uptick in its stock price over the past week, even as broader sentiment in the healthcare sector remains mixed. Investors are closely ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-assessing-valuation-after-rec\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Angelalign Technology (SEHK:6699): Assessing Valuation After Recent Share Price Uptick</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAngelalign Technology (SEHK:6699): Assessing Valuation After Recent Share Price Uptick\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-04 03:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-assessing-valuation-after-rec><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Angelalign Technology (SEHK:6699) has experienced a modest uptick in its stock price over the past week, even as broader sentiment in the healthcare sector remains mixed. Investors are closely ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-assessing-valuation-after-rec\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06699","symbol_name":"时代天使","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-assessing-valuation-after-rec","article_id":"2572639630","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-sehk6699-assessing-valuation-after-rec","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2572639630","pubTimestamp":1759518206,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Angelalign Technology (SEHK:6699) has experienced a modest uptick in its stock price over the past week, even as broader sentiment in the healthcare sector remains mixed. Investors are closely watching the company's recent performance trends.\nSee our latest analysis for Angelalign Technology.\nShares of Angelalign Technology have been edging higher lately, hinting at renewed optimism after a period of subdued performance. While the latest momentum suggests investors are warming to the growth...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"06699":"时代天使","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK1583":"高瓴概念","BK1593":"医美概念股","BK1100":"医疗保健设备","BK1587":"次新股"},"translate_title":"时代天使科技（SEHK：6699）：近期股价上涨后评估估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06699":1.5,"DCF":1},"content_text":"Angelalign Technology (SEHK:6699) has experienced a modest uptick in its stock price over the past week, even as broader sentiment in the healthcare sector remains mixed. Investors are closely watching the company's recent performance trends. See our latest analysis for Angelalign Technology. Shares of Angelalign Technology have been edging higher lately, hinting at renewed optimism after a period of subdued performance. While the latest momentum suggests investors are warming to the growth story, the 1-year total shareholder return is still in negative territory, reflecting the ongoing recovery mode for the stock in both the short term and long term. If you're watching Angelalign and want to broaden your outlook, consider exploring See the full list for free. for more healthcare names moving the market right now. With Angelalign’s recent gains and strong revenue growth, investors are left to wonder if the current price is still a bargain or whether the market has already accounted for the next stage of expansion. AdvertisementPrice-to-Earnings of 59.8x: Is it justified? Angelalign Technology is trading at a price-to-earnings ratio of 59.8x, substantially above the average for its industry, despite its share price closing at HK$64.3 most recently. This lofty multiple suggests investors are paying a premium for future growth prospects. The price-to-earnings (P/E) ratio measures how much investors are willing to pay for each dollar of the company's current earnings. In the medical equipment sector, a high P/E can reflect expectations of rapid, sustainable profit growth or a competitive edge. Despite this optimism, Angelalign's P/E far exceeds the Hong Kong Medical Equipment industry average of 20.9x and the peer average of 47.6x. The figure is also nearly triple the estimated fair P/E ratio of 20x, which highlights a major divergence between price and more conservative benchmarks the market could eventually gravitate toward. Explore the SWS fair ratio for Angelalign Technology Result: Price-to-Earnings of 59.8x (OVERVALUED) However, slower revenue growth or a sudden shift in investor sentiment could quickly diminish the current premium that investors are willing to pay. Find out about the key risks to this Angelalign Technology narrative. Another View: DCF Model Suggests Undervaluation Taking a different approach, our SWS DCF model estimates Angelalign Technology’s fair value at HK$70.61. This makes the current price of HK$64.3 about 8.9% below this figure. While the earlier multiples imply overvaluation, this method points to possible upside. Which valuation will the market trust? Look into how the SWS DCF model arrives at its fair value. 6699 Discounted Cash Flow as at Oct 2025Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Angelalign Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.  Build Your Own Angelalign Technology Narrative If you have a different perspective or want to dig deeper into the numbers yourself, you can easily build your own narrative in just a few minutes. Do it your way A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Angelalign Technology. Looking for more investment ideas? Don’t let great opportunities pass you by. Some of the market’s most promising stocks are just a click away with the right screeners on your side.  Capture growth by zeroing in on these 904 undervalued stocks based on cash flows, where quality companies may be trading below their true potential. Take charge of your income goals with these 19 dividend stocks with yields > 3% offering reliable yields that help boost your portfolio stability. Stay ahead of the curve by searching out tomorrow’s breakthroughs among these 24 AI penny stocks reshaping industries with innovative technology.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}